BridgeMD
New treatment option for Lepidic-Predominant Lung Adenocarcinoma
Official title Low-glucose/High-fat Intake Dietary Regimen as a Tool for Empowering Diagnostic Accuracy of 2-[18F]FDG PET/CT in Lepidic-predominant Growth Lung Adenocarcinoma
ClinicalTrials.gov ID: NCT07479095
What this study is testing
- What it's testing
- This study evaluates whether a 7-day ketogenic dietary regimen before 2-[18F]FDG PET/CT can improve the diagnostic accuracy of imaging in adults with suspected or histologically confirmed lepidic-predominant lung adenocarcinoma (LPA). LPA frequently shows low glucose metabolism and may yield false-negative FDG PET/CT results.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Written informed consent.
- Age 18 years or older.
- CT evidence of a lung nodule suspicious for LPA or lung biopsy positive for LPA.
- Target nodule diameter at least 10 mm.
- ECOG performance status 0 to 2.
You likely can't join if
- Not suitable for prolonged imaging procedures.
- Renal failure.
- Type 1 diabetes mellitus.
- Pancreatitis.
- Severe dyslipidemia.
- Other malignancies that are progressing or required active treatment within the previous 3 years.
See the full eligibility criteria
- Written informed consent.
- Age 18 years or older.
- CT evidence of a lung nodule suspicious for LPA or lung biopsy positive for LPA.
- Target nodule diameter at least 10 mm.
- ECOG performance status 0 to 2.
- Willingness and ability to adhere to a controlled ketogenic diet for 7 days.
- Ability to comply with study procedures and visit schedule.
- Not suitable for prolonged imaging procedures.
- Renal failure.
- Type 1 diabetes mellitus.
- Pancreatitis.
- Severe dyslipidemia.
- Other malignancies that are progressing or required active treatment within the previous 3 years.
- Serious or unstable medical, psychiatric, or substance use disorders that could interfere with study participation.
- Pregnancy or breastfeeding.
- Refusal to participate
The study team makes the final eligibility decision.
Where it's taking place
- Candiolo, Torino (TO), Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Candiolo, Torino (TO), Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.